Catalyst Funds Management Pty LTD Royalty Pharma PLC Transaction History
Catalyst Funds Management Pty LTD
- $382 Billion
- Q1 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 66,280 shares of RPRX stock, worth $2.25 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
66,280Holding current value
$2.25 Million% of portfolio
0.54%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
485Shares Held
282MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.4 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$783 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$456 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$414 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.9B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...